Literature DB >> 19931029

Beams arrangement in non-small cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis.

Sara Ramella1, Lucio Trodella, Tommaso Claudio Mineo, Eugenio Pompeo, Maria A Gambacorta, Francesco Cellini, Marzia Ciresa, Michele Fiore, Carlo Greco, Diego Gaudino, Gerardina Stimato, Angelo Piermattei, Alfredo Cesario, Rolando M D'Angelillo.   

Abstract

The aim of this study is to propose and validate an original new class of solutions for three-dimensional conformal radiation therapy (3DCRT) treatment planning for non-small cell lung cancer (NSCLC) according to the different patterns of disease presentation (on the basis of tumor location and volume) and to explore beams arrangement (planar or no-planar solutions) to respect dose constraints to the lung parenchyma. Benchmarks matched to validate the new approach are interuser reproducibility and saving on planning time. Tumor location was explored and specific categories created according to the tumor volume and location. Therefore, by applying planar and no-planar 3D plans, we searched for an optimization of the beams arrangement for each category. Dose-volume histograms (DVHs) were analyzed and a plan comparison performed. Results were then validated (class solution planning confirmation) by applying the same strategy to another group of patients. This has been realized at two dose levels (50.4 and 59.4 Gy). Fifty-nine patients were enrolled in this dosimetric study. In the first 27 patients ("exploratory sample") three main planning target volume location categories were identified according to the pattern of the disease presentation: (1) centrally located; (2) peripheral T and mediastinal N (P+N); and (3) superior sulcus. Original class solutions were proposed for each location category. On the next 32 patients ("validation sample"), the treatment planning started directly with the recommended approach. Mean V(20 Gy) value was 18.8% (SD +/- 7.25); mean V(30 Gy):12% (SD +/- 4.05); and mean lung dose: 11.6 Gy (SD +/- 5.77). No differences between the two total dose level groups were observed. These results suggest a simple and reproducible tool for treatment planning in NSCLC, allowing interuser reproducibility and cutting down on planning time. 2010 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19931029     DOI: 10.1016/j.meddos.2009.05.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  2 in total

1.  A data-driven approach to optimal beam/arc angle selection for liver stereotactic body radiation therapy treatment planning.

Authors:  Yang Sheng; Taoran Li; Yaorong Ge; Hui Lin; Wentao Wang; Lulin Yuan; Q Jackie Wu
Journal:  Quant Imaging Med Surg       Date:  2021-12

2.  Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results.

Authors:  Sara Ramella; Antonio Maria Alberti; Eugenio Cammilluzzi; Michele Fiore; Edy Ippolito; Carlo Greco; Angelo Luca De Quarto; Sara Ramponi; Giovanni Apolone; Lucio Trodella; Alfredo Cesario; Rolando Maria D'Angelillo
Journal:  Biomed Res Int       Date:  2013-08-04       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.